PAG
DNA icon

Private Advisor Group’s Ginkgo Bioworks DNA Stock Holding History

Private Advisor Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-770
Closed -$10.3K – 2444
2024
Q2 		$10.3K Buy
770
+89
+13% +$2.65K ﹤0.01% 2316
2024
Q1 		$31.6K Buy
681
+233
+52% +$12.1K ﹤0.01% 2258
2023
Q4 		$30.3K Buy
448
+151
+51% +$9.25K ﹤0.01% 2177
2023
Q3 		$21.5K Sell
297
-183
-38% -$14.6K ﹤0.01% 2102
2023
Q2 		$35.7K Hold
480
– – ﹤0.01% 1982
2023
Q1 		$25.5K Buy
480
+115
+32% +$7.29K ﹤0.01% 1925
2022
Q4 		$25 Buy
+365
New +$33.6K ﹤0.01% 1638
2022
Q3 		– Sell
-468
Closed -$44K – 1971
2022
Q2 		$44K Buy
+468
New +$57.1K ﹤0.01% 2021

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return